SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-18-004756
Filing Date
2018-03-15
Accepted
2018-03-15 16:19:16
Documents
115
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K navb20171231_10k.htm 10-K 3439804
2 EXHIBIT 21.1 ex_107678.htm EX-21.1 4528
3 EXHIBIT 23.1 ex_107679.htm EX-23.1 3912
4 EXHIBIT 23.2 ex_107680.htm EX-23.2 3138
5 EXHIBIT 24.1 ex_107681.htm EX-24.1 16005
6 EXHIBIT 31.1 ex_107682.htm EX-31.1 10662
7 EXHIBIT 31.2 ex_107683.htm EX-31.2 10611
8 EXHIBIT 32.1 ex_107684.htm EX-32.1 5323
9 EXHIBIT 32.2 ex_107685.htm EX-32.2 5322
16 img.jpg GRAPHIC 8735
17 chart.jpg GRAPHIC 25268
  Complete submission text file 0001437749-18-004756.txt   14882615

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT navb-20171231.xml EX-101.INS 2976134
11 XBRL TAXONOMY EXTENSION SCHEMA navb-20171231.xsd EX-101.SCH 125696
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20171231_cal.xml EX-101.CAL 84904
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20171231_def.xml EX-101.DEF 1029994
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20171231_lab.xml EX-101.LAB 764819
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20171231_pre.xml EX-101.PRE 1055170
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 18692638
SIC: 2835 In Vitro & In Vivo Diagnostic Substances